The European Board of Anaesthesiology recommendations for safe medication practice: First update

David Whitaker*, Guttorm Brattebø, Stefan Trenkler, Indulis Vanags, Flavia Petrini, Zuhal Aykac, Dan Longrois, Stephan Alexander Loer, Tomasz Gaszynski, Jurate Sipylaite, Elena Copaciu, Vladimir Cerny, Jonas Akeson, Jannicke Mellin-Olsen, Carmel Abela, Adela Stecher, Sibylle Kozek-Langenecker, Indrek Rätsep

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

These European Board of Anaesthesiology (EBA) recommendations for safe medication practice replace the first edition of the EBA recommendations published in 2011. They were updated because evidence from critical incident reporting systems continues to show that medication errors remain a major safety issue in anaesthesia, intensive care, emergency medicine and pain medicine, and there is an ongoing need for relevant up-to-date clinical guidance for practising anaesthesiologists. The recommendations are based on evidence wherever possible, with a focus on patient safety, and are primarily aimed at anaesthesiologists practising in Europe, although many will be applicable elsewhere. They emphasise the importance of correct labelling practice and the value of incident reporting so that lessons can be learned, risks reduced and a safety culture developed.

Original languageEnglish
Pages (from-to)4-7
Number of pages4
JournalEuropean Journal of Anaesthesiology
Volume34
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017

Cite this

Whitaker, D., Brattebø, G., Trenkler, S., Vanags, I., Petrini, F., Aykac, Z., ... Rätsep, I. (2017). The European Board of Anaesthesiology recommendations for safe medication practice: First update. European Journal of Anaesthesiology, 34(1), 4-7. https://doi.org/10.1097/EJA.0000000000000531